Since increased Adipoq and Ucp1 levels contribute to heart failure pathogenesis [21,122], the Grk2 inhibition-induced normalisation of pathologically elevated Adipoq and Ucp1 levels is a desired, positive therapeutic effect and not an adverse effect. The gene discussed is ADIPOQ; the disease is heart failure.